M2, Recombinant, Influenza A Virus, aa1-22, His-Tag (Matrix Protein 2)

Cat# 374112-100ug

Size : 100ug

Brand : US Biological

Contact local distributor :


Phone : +1 850 650 7790


374112 M2, Recombinant, Influenza A Virus, aa1-22, His-Tag (Matrix Protein 2)

Swiss Prot
A4GCM0
Grade
Purified
Shipping Temp
Blue Ice
Storage Temp
-20°C

Forms a proton-selective ion channel that is necessary for the efficient release of the viral genome during virus entry. After attaching to the cell surface, the virion enters the cell by endocytosis. Acidification of the endosome triggers M2 ion channel activity. The influx of protons into virion interior is believed to disrupt interactions between the viral ribonucleoprotein (RNP), matrix protein 1 (M1), and lipid bilayers, thereby freeing the viral genome from interaction with viral proteins and enabling RNA segments to migrate to the host cell nucleus, where influenza virus RNA transcription and replication occur. Also plays a role in viral proteins secretory pathway. Elevates the intravesicular pH of normally acidic compartments, such as trans-Golgi network, preventing newly formed hemagglutinin from premature switching to the fusion-active conformation.

Partial recombinant protein corresponding to aa1-22 from infuenza A virus M2 (strain A/USA:Phila/1935 H1N1), fused to 6X His-Tag at N-terminal expressed in E. coli. Swiss/Uniprot Accession: A4GCM0

Molecular Weight:
~6.5kD

Amino Acid Sequence:
MSLLTEVETPIRNEWGCRCNGS

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months after receipt at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Applications
Source: Recombinant, E. coli|Purity: ≥90% (SDS-PAGE)|Concentration: As Reported |Form: Supplied as a liquid in Tris-HCl, pH 8.0, 0.15M sodium chloride, 50% glycerol.||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Form
Supplied as a liquid in Tris-HCl, pH 8.0, 0.15M sodium chloride, 50% glycerol.
Purity
≥90% (SDS-PAGE)
References
1. "The NIAID influenza genome sequencing project." Ghedin E., Spiro D., Miller N., Zaborsky J., Feldblyum T., Subbu V., Shumway M., Sparenborg J., Groveman L., Halpin R., Sitz J., Koo H., Salzberg S.L., Webster R.G., Hoffmann E., Krauss S., Naeve C., Bao Y. Tatusova T.Submitted (MAR-2007).